SG11202106998TA - Strains, composition and method of use - Google Patents
Strains, composition and method of useInfo
- Publication number
- SG11202106998TA SG11202106998TA SG11202106998TA SG11202106998TA SG11202106998TA SG 11202106998T A SG11202106998T A SG 11202106998TA SG 11202106998T A SG11202106998T A SG 11202106998TA SG 11202106998T A SG11202106998T A SG 11202106998TA SG 11202106998T A SG11202106998T A SG 11202106998TA
- Authority
- SG
- Singapore
- Prior art keywords
- strains
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201900009 | 2019-01-04 | ||
| DKPA201900469 | 2019-04-17 | ||
| PCT/EP2019/071348 WO2020098988A1 (en) | 2019-01-04 | 2019-08-08 | Strains, composition and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106998TA true SG11202106998TA (en) | 2021-07-29 |
Family
ID=68104556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106998TA SG11202106998TA (en) | 2019-01-04 | 2019-08-08 | Strains, composition and method of use |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220110986A1 (en) |
| EP (1) | EP3906300A1 (en) |
| JP (2) | JP2022517754A (en) |
| KR (1) | KR20210112342A (en) |
| CN (1) | CN113474447A (en) |
| AU (1) | AU2019379234A1 (en) |
| BR (1) | BR112021013190A2 (en) |
| CA (1) | CA3123125A1 (en) |
| SG (1) | SG11202106998TA (en) |
| WO (1) | WO2020098988A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020279533A1 (en) * | 2019-05-20 | 2021-12-23 | Lactobio A/S | Composition for treatment, alleviation or prophylaxis of acne |
| JP2023547196A (en) * | 2020-11-05 | 2023-11-09 | ラクトバイオ アー／エス | Novel compositions for treating skin conditions |
| CN114504108B (en) * | 2020-11-16 | 2023-06-02 | 内蒙古伊利实业集团股份有限公司 | Composition containing lactobacillus paracasei and breast milk oligosaccharide and application thereof |
| WO2022171654A1 (en) * | 2021-02-09 | 2022-08-18 | Lactobio A/S | Method for treating atopic disorders |
| CN114854623B (en) * | 2022-03-15 | 2023-09-29 | 泸州老窖股份有限公司 | Lactobacillus delbrueckii subspecies bulgaricus, microbial inoculum containing lactobacillus delbrueckii subspecies bulgaricus and application of lactobacillus delbrueckii subspecies bulgaricus |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| FI92498C (en) | 1992-06-10 | 1994-11-25 | Valio Meijerien | New microorganism strain, bacterial preparations containing it and their use for controlling yeast and mold |
| KR101381547B1 (en) * | 2007-10-19 | 2014-04-17 | 대상에프앤에프 주식회사 | Novel Leuconostoc mesenteroides from kimchi with inhibiting activities on pathogenic microorganism and use thereof |
| RU2557310C2 (en) | 2009-11-11 | 2015-07-20 | Алиментари Хелс Лимитед | Bifidobacterium longum STRAIN, SUITABLE FOR APPLICATION IN IMMUNOMODULATION, INDUCTION OF CYTOKINS PRODUCTION, TREATMENT OF AUTOIMMUNE DISEASE, CONTROL OF IL - 10:IL - 12 RATIO, AND APPLICATION THEREOF |
| US8470583B1 (en) * | 2010-09-23 | 2013-06-25 | The United States Of America, As Represented By The Secretary Of Agriculture | Lactobacillus strain and bacteriocin |
| KR101258692B1 (en) * | 2010-10-14 | 2013-04-29 | 대한민국 | Weissella viridescens for the growth inhibiting of antibiotic resistant Staphylococcus aureus(MRSA) |
| KR20120121184A (en) * | 2011-04-26 | 2012-11-05 | 주식회사 알엔에이 | Antimicrobial Composition against Methicillin resistant Staphylococcus aureus |
| CN103502434B (en) * | 2011-05-06 | 2016-08-17 | 有机平衡医疗股份公司 | Lactic acid bacteria and the compositions containing this lactic acid bacteria |
| FR2999601B1 (en) * | 2012-12-17 | 2015-01-30 | Urgo Lab | METHOD FOR PREVENTING AND / OR TREATING INFECTIONS, COLONIZATIONS OR DISEASES ASSOCIATED WITH STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA, STREPTOCOCCUS PYOGENES, ENTEROCOCCUS FAECIUM, ENTEROBACTER CLOACAE, PROTEUS MIRABILIS AND / OR BACTEROIDES FRAGILIS |
| US20140308258A1 (en) * | 2013-04-12 | 2014-10-16 | Charles Joseph Matthews | Enhanced microbial strains for the prevention and treatment of methicillin-resistant staphylococcus aureus and methicillin-resistant staphylococcus epidermis infection |
| EP3180012A1 (en) * | 2014-08-13 | 2017-06-21 | Nestec S.A. | Lactobacillus plantarum cncm i-4026 preparations and skin health |
| CN108048352B (en) * | 2017-12-22 | 2021-04-20 | 华中农业大学 | Enterococcus faecium XC2 capable of producing antibacterial substances and screening method and application thereof |
-
2019
- 2019-08-08 JP JP2021539141A patent/JP2022517754A/en active Pending
- 2019-08-08 CA CA3123125A patent/CA3123125A1/en active Pending
- 2019-08-08 BR BR112021013190-6A patent/BR112021013190A2/en unknown
- 2019-08-08 SG SG11202106998TA patent/SG11202106998TA/en unknown
- 2019-08-08 AU AU2019379234A patent/AU2019379234A1/en active Pending
- 2019-08-08 KR KR1020217024462A patent/KR20210112342A/en unknown
- 2019-08-08 CN CN201980087864.2A patent/CN113474447A/en active Pending
- 2019-08-08 US US17/417,654 patent/US20220110986A1/en active Pending
- 2019-08-08 EP EP19773724.0A patent/EP3906300A1/en active Pending
- 2019-08-08 WO PCT/EP2019/071348 patent/WO2020098988A1/en unknown
-
2023
- 2023-10-24 JP JP2023182408A patent/JP2024023182A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113474447A (en) | 2021-10-01 |
| JP2022517754A (en) | 2022-03-10 |
| EP3906300A1 (en) | 2021-11-10 |
| AU2019379234A1 (en) | 2021-07-29 |
| WO2020098988A1 (en) | 2020-05-22 |
| BR112021013190A2 (en) | 2021-09-28 |
| KR20210112342A (en) | 2021-09-14 |
| CA3123125A1 (en) | 2020-05-22 |
| US20220110986A1 (en) | 2022-04-14 |
| JP2024023182A (en) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202106998TA (en) | Strains, composition and method of use | |
| GB201905559D0 (en) | Composition and method | |
| SG10201910740UA (en) | Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same | |
| GB2572610B (en) | Composition, methods for its production, and its use | |
| EP3510134A4 (en) | Cleaning composition, method of making and use thereof | |
| GB201909542D0 (en) | Composition and method | |
| GB201901099D0 (en) | Methods, uses and compositions | |
| IL285792A (en) | Composition and container, kit, method of use | |
| IL289586A (en) | Micromolecule pi4kiiialpha inhibitor composition, preparation method therefor and use thereof | |
| GB201904104D0 (en) | Composition, method and use | |
| EP3777862A4 (en) | Meloxicam composition, preparation and preparation method and use thereof | |
| GB2564511B (en) | Composition, method and use | |
| GB201805016D0 (en) | Composition, method and use | |
| GB2587074B (en) | Composition, paste and methods | |
| GB2562116B (en) | Metal oxide, composition comprising the same and method of making metal oxide | |
| GB201705124D0 (en) | Composition, method and use | |
| GB201911367D0 (en) | Composition, paste and methods | |
| EP3355864A4 (en) | Composition for reducing the frequency of urination, method of making and use thereof | |
| GB2579687B (en) | Composition and method | |
| GB201914777D0 (en) | Composition and method | |
| SG11202007881SA (en) | Laminate, composition, production method of laminate, and production method of member | |
| GB201900569D0 (en) | Composition, method and use thereof | |
| GB202107977D0 (en) | Method, composition and use | |
| AU2019902241A0 (en) | Composition and method | |
| EP3735246A4 (en) | Mito-lonidamine, compositions and methods of use |